Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Building an MBMA Framework to Support Developing New Neuropathic Pain Drugs

Model-Based Meta-Analysis (MBMA) is a growing methodology that leverages literature based and often external data to provide a quantitative framework to enable strategic drug development decisions. MBMA comparator models often include valuable pieces of information such as time, covariates, clinical trial efficacy and safety information.

Speaker(s): Leticia Arrington, Richard C. Franzese
Solution: Model-based Meta-analysis, PK/PD Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info
Learn More LinkedIn Twitter Facebook Email

Powered by GlobalLink OneLink Software